Comparing physical activity measurements in cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the physical activity levels of patients undergoing treatment for lymphoma, pancreatic cancer, or colorectal cancer using both questionnaires and motion trackers. The aim is to compare the effectiveness of these two assessment methods to determine which provides a more accurate measure of physical activity during cancer therapy. By analyzing data collected at various time points, the study seeks to enhance the understanding of physical activity's role in cancer treatment outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* verified diagnosis of lymphoma, colorectal or pancreatic cancer
* requirement of surgical, chemo or radio therapy
* provision of informed consent

Exclusion Criteria:

* pregnancy
* inability to provide consent
* use of a rollator

Where it's running

• University Medicine Greifswald
  Greifswald, Germany Recruiting

Study contacts

• Principal investigator: Ali A Aghdassi, Professor — University Medicine Greifswald
• Study coordinator: Ali A Aghdassi, Professor
• Email: ali.aghdassi@med.uni-greifswald.de
• Phone: +493834867230

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• A network for collaborative cancer research in Ontario

  This study is testing a new way to improve cancer treatment by using genetics and technology to help personalize care for people with different types of cancer.

  Recruiting at 2 sites University Health Network, Toronto · Kingston, Ontario and 2 other locations · NCT05403177

• Phone app for remote symptom monitoring and management during cancer treatment

  This trial will test whether the ASSIST smartphone app can be used and is liked by people with breast cancer, colorectal cancer, or lymphoma who are starting systemic treatment.

  Recruiting Massachusetts General Hospital · Boston, Massachusetts · NCT07553572

• Carbon nanoparticle‑loaded iron for advanced solid tumors

  This test uses direct injections of a carbon nanoparticle‑loaded iron medicine (CNSI‑Fe) to see if it can shrink tumors in adults with advanced solid cancers who have no effective standard treatment options.

  Recruiting at 4 sites Phase 1/2 Sichuan Enray Pharmaceutical Sciences Company · Beijing, Beijing Municipality and 8 other locations · NCT07433283

• Using Riluzole to Help Breast Cancer Survivors with Cognitive Issues

  This study is testing if the medication riluzole can help breast cancer survivors who are having trouble with thinking and memory feel better.

  Recruiting Phase 2 University of California, Irvine · Orange, California · NCT06580002

• Personalized nutrition and exercise program for cancer survivors

  This study is testing whether a personalized nutrition and exercise program can help breast, prostate, or colorectal cancer survivors eat healthier and be more active.

  Recruiting University of Miami · Miami, Florida · NCT06534918

• Milaberon for treating advanced solid tumors

  This study is testing if a higher dose of mirabegron can help people with advanced solid tumors feel better while keeping an eye on any side effects.

  Recruiting Phase 2 Zhejiang Provincial People's Hospital · Hangzhou, Zhejiang · NCT06534762

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.